121 related articles for article (PubMed ID: 28717246)
1. Estimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in Korea.
Lee JY; Ock M; Jo MW; Son WS; Lee HJ; Kim SH; Kim HJ; Lee JL
Sci Rep; 2017 Jul; 7(1):5571. PubMed ID: 28717246
[TBL] [Abstract][Full Text] [Related]
2. Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea.
Kim EJ; Ock M; Kim KP; Jung NH; Lee HJ; Kim SH; Jo MW
BMC Cancer; 2018 Nov; 18(1):1081. PubMed ID: 30409116
[TBL] [Abstract][Full Text] [Related]
3. Estimating quality-adjusted life-year loss due to noncommunicable diseases in Korean adults through to the year 2040.
Ock M; Han JW; Lee JY; Kim SH; Jo MW
Value Health; 2015 Jan; 18(1):61-6. PubMed ID: 25595235
[TBL] [Abstract][Full Text] [Related]
4. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
[TBL] [Abstract][Full Text] [Related]
5. Estimation of utility weights for major liver diseases according to disease severity in Korea.
Ock M; Lim SY; Lee HJ; Kim SH; Jo MW
BMC Gastroenterol; 2017 Sep; 17(1):103. PubMed ID: 28870162
[TBL] [Abstract][Full Text] [Related]
6. Burden of Visual Impairment and Chronic Diseases.
Park SJ; Ahn S; Park KH
JAMA Ophthalmol; 2016 Jul; 134(7):778-84. PubMed ID: 27196876
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Screening Colonoscopy in Iranian High Risk Population.
Javadinasab H; Daroudi R; Salimzadeh H; Delavari A; Vezvaie P; Malekzadeh R
Arch Iran Med; 2017 Sep; 20(9):564-571. PubMed ID: 29048918
[TBL] [Abstract][Full Text] [Related]
8. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.
Gini A; Zauber AG; Cenin DR; Omidvari AH; Hempstead SE; Fink AK; Lowenfels AB; Lansdorp-Vogelaar I
Gastroenterology; 2018 Feb; 154(3):556-567.e18. PubMed ID: 29102616
[TBL] [Abstract][Full Text] [Related]
10. Estimation of population-based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation.
Jo MW; Lee HJ; Ryu DR; Park J; Ock M; Kim SH
Nephrology (Carlton); 2020 Jul; 25(7):544-550. PubMed ID: 32026549
[TBL] [Abstract][Full Text] [Related]
11. Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.
Yang SC; Lai WW; Chang HY; Su WC; Chen HH; Wang JD
Lung Cancer; 2014 Oct; 86(1):96-101. PubMed ID: 25178685
[TBL] [Abstract][Full Text] [Related]
12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
[TBL] [Abstract][Full Text] [Related]
14. Updating Disability Weights for Measurement of Healthy Life Expectancy and Disability-adjusted Life Year in Korea.
Kim YE; Jo MW; Park H; Oh IH; Yoon SJ; Pyo J; Ock M
J Korean Med Sci; 2020 Jul; 35(27):e219. PubMed ID: 32657086
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
16. Valuing SF-6D Health States Using a Discrete Choice Experiment.
Norman R; Viney R; Brazier J; Burgess L; Cronin P; King M; Ratcliffe J; Street D
Med Decis Making; 2014 Aug; 34(6):773-86. PubMed ID: 24025661
[TBL] [Abstract][Full Text] [Related]
17. Regional Differences in Colorectal Cancer Mortality Between 2000 and 2013 in Republic of Korea.
Woo HT; Sim JA; Mo J; Yun YH; Shin A
J Epidemiol; 2019 Oct; 29(10):399-405. PubMed ID: 30298861
[TBL] [Abstract][Full Text] [Related]
18. Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.
Hung MC; Lai WW; Chen HH; Su WC; Wang JD
Cancer Epidemiol; 2015 Feb; 39(1):126-32. PubMed ID: 25553846
[TBL] [Abstract][Full Text] [Related]
19. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
Berger BM; Schroy PC; Dinh TA
Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
[TBL] [Abstract][Full Text] [Related]
20. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
